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ABSTRACT
The ability to target methylation to specific genomic
sites would further the study of DNA methylation’s
biological role and potentially offer a tool for
silencing gene expression and for treating
diseases involving abnormal hypomethylation. The
end-to-end fusion of DNA methyltransferases to
zinc fingers has been shown to bias methylation to
desired regions. However, the strategy is inherently
limited because the methyltransferase domain
remains active regardless of whether the zinc
finger domain is bound at its cognate site and can
methylate non-target sites. We demonstrate an
alternative strategy in which fragments of a DNA
methyltransferase, compromised in their ability to
methylate DNA, are fused to two zinc fingers
designed to bind 9bp sites flanking a methylation
target site. Using the naturally heterodimeric DNA
methyltransferase M.EcoHK31I, which methylates
the inner cytosine of 50-YGGCCR-30, we demon-
strate that this strategy can yield a methyltrans-
ferase capable of significant levels of methylation
at the target site with undetectable levels of
methylation at non-target sites in Escherichia coli.
However, some non-target methylation could be
detected at higher expression levels of the zinc
finger methyltransferase indicating that further
improvements will be necessary to attain the
desired exclusive target specificity.
INTRODUCTION
Methylation of cytosine residues is a key epigenetic mod-
iﬁcation of genomes. Methylation patterns appear to play
key roles in normal developmental processes and diseases.
A variety of evidence indicates that methylation of CpG
sites is involved in shaping chromatin structure, silencing
of parasitic DNA and regulating gene expression.
Genomic methylation patterns are species dependent
but mammalian cells normally exhibit global CpG
methylation, with small regions of non-methylated DNA
(1). These unmethylated sequences correspond to dense
regions of CpG sequences (CpG islands) that occur in
known promoter regions. Hypomethylated islands corre-
spond to actively transcribed genes, and when these
promoter regions become hypermethylated the gene is
silenced. Methylation in promoter regions can inhibit the
binding of transcription factors (2,3) and may signal
chromatin remodeling to further prevent transcription.
The ability to speciﬁcally target single sites or regions in
CpG islands for methylation would be very useful for the
study of DNA methylation, for the silencing of genes
of interest, and as a potential therapeutic strategy for
diseases involving abnormal hypomethylation. Targeted
methylation of promoter regions has been demonstrated
to reduce transcriptional activity in vitro and in vivo (4,5);
however, the issue of speciﬁcity (the diﬀerence between
levels of exogenously derived methylation at target and
non-target sites) is paramount. Abnormal methylation
patterns have been linked to several diseases, cancer
being the most studied. To prevent any unintended or
adverse consequences, the amount of non-target methy-
lation must be eliminated or greatly reduced to prevent
deleterious eﬀects.
Current methods of targeting DNA methylation
include genetically fusing methyltransferases to DNA
binding domains to localize the methyltransferase next
to a target methylation site (4–11). However, since the
methyltransferase domain presumably remains active in
the absence of the DNA binding domain associating
with its target site, the methyltransferase is free to
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Thus, the level of speciﬁcity that can be achieved by this
approach is inherently limited. Accordingly, analyses of
the methylation patterns created using this strategy have
shown methylation both at target and non-target sites,
but with preferential methylation at target sites over
non-target sites (5,8,11). This non-target methylation
limits the use of these fusion proteins as a research tool
and raises the concern that unintended side eﬀects
resulting from non-target methylation could be a serious
drawback for any therapeutic applications of these fusions
in the future (12). The use of mutant methyltransferases
with reduced activity has been proposed as an approach
for improving speciﬁcity (6), but this strategy only serves
as a route to achieving the optimum bias such fusions
can oﬀer and does not address the fundamental limitation
of the approach.
To create a truly site-speciﬁc methyltransferase,
methyltransferase activity must require the association of
the DNA binding domain and its target site. An attractive
route to achieving this goal involves splitting naturally
monomeric methyltransferases into two fragments and
fusing the fragments to diﬀerent DNA binding domains
that bind DNA ﬂanking the target site for methylation
(Figure 1A) (13,14). For the success of this strategy, the
fragments must not appreciably associate in a functional
form in solution (or when only one fragment is bound to
DNA). This property could result from the fragments’ dis-
sociation constant being signiﬁcantly above their cellular
concentration. In contrast, when both fragments are
bound to proximal sites on the DNA, their local, eﬀective
concentration increases above the Kd (and the association
also can be facilitated due to entropic reasons if the frag-
ments are oriented correctly) and an active methyltransferase
is formed that can only methylate the target site. In addition,
the proximity of the two fragments might assist attainment
of the correct folded structure, as has been observed with
protein complementation assays (15).
Here, we have taken the approach of starting with a
naturally heterodimeric methyltransferase and reducing
its association through mutagenesis (by creating deletion
mutants) before fusion of the fragments to DNA binding
domains. This approach seemed more tractable than
using artiﬁcially split methyltransferases (13,14) since
natural heterodimeric methyltransferases have evolved to
be produced as separate polypeptides. We chose the
methyltransferase M.EcoHK31I as our model protein.
M.EcoHK31I has a and b peptide chains that require
association for methyltransferase activity (16). The gene
encoding M.EcoHK31I has an unusual architecture. The
b chain is encoded entirely within a diﬀerent reading
frame of the a fragment. The large a fragment contains
both the DNA binding domain and the catalytic domain
(motifs I–VIII and X and TRD), whereas the smaller b
fragment contains motif IX that helps stabilize site-speciﬁc
binding (17). M.EcoHK31I recognizes the sequence
50-YGGCCR-30 and methylates the innermost cytosine.
Although M.EcoHK31I does not methylate CpG
sequences, it is an attractive model protein for testing
our strategy. Previous in vitro studies of M.EcoHK31I
have shown that deletions of at least 42-amino acid
residues from the N-terminus of the b fragment eliminated
methylation activity due to a decrease in the association
of the two fragments (17). Furthermore, there is growing
evidence of the occurrence of non-CpG methylation
in mammalian genomes of diseased or cancerous cells
(18,19) and embryonic stem cells (20). Any targeted
methyltransferase we create from M.EcoHK31I may ﬁnd
use for the study of this type of methylation or for the
study of non-CpG methylation found in plants and other
organisms.
MATERIALS AND METHODS
Plasmids
Restriction enzymes, T4 DNA ligase and T4
polynucleotide kinase were purchased from New England
Biolabs (Ipswich, MA, USA) and used according to man-
ufacturer’s instructions. Agarose gel electrophoresis and
PCR were performed essentially as described (21).
Escherichia coli K-12 strain ER2267 [F0 proA
+B
+ lacI
q
D(lacZ)M15 zzf::mini-Tn10 (Kan
R)/ D(argF-lacZ)U169
glnV44 e14
 (McrA
 ) rfbD1? recA1 relA1? endA1 spoT1?
thi-1 D(mcrC-mrr)114::IS10] was obtained from New
England Biolabs (Ipswich, MA, USA) and was used
as a host for DNA cloning experiments and methylation
protection assays. Cells were grown in LB media supple-
mented with chloramphenicol (50mg/ml) and/or
ampicillin (100mg/ml). All DNA primers were obtained
from Invitrogen (Carlsbad, CA, USA). Detailed descrip-
tions of plasmid modiﬁcations and the creation of
methyltransferase fragment constructs can be found in
Supplementary Data.
Construction of pDIM-N7 and pAR for expression of
M.EcoHK31I fragments
Expression plasmids were derived from pDIM-N7-
MHhaI[1–302] and pAR-MHhaI[29–327] (22). Plasmids
containing the M.EcoHK31IA and M.EcoHK31IB genes
were a gift from Shaw (16). The M.EcoHK31IA and
M.EcoHK31IB genes were ampliﬁed by PCR and
inserted into pDIM-N7 and pAR plasmids, respectively.
The truncated M.EcoHK31IB fragments were ampliﬁed
using the appropriate primers to create truncations
ranging from 35- to 50-amino acid residues. The ampliﬁed
truncated fragment was then inserted into pAR plasmid
(see Supplementary Figure S2, Supplementary Data, for
detailed plasmid maps).
Construction of pDIM-N7 Tyr123-a and pAR b-Tyr456
plasmids for combinatorial library
The target sites were designed with a methylation site
(50-CGGCCG-30) ﬂanked by the Tyr123 and Tyr456 zinc
ﬁnger binding sites (Figure 1A). The zinc ﬁnger DNA
binding sites are separated from the methylation site by
0, 1, 2 or 3bp (labeled 0, 1, 2 and 3bp target sites) with the
methylation site centered between the zinc ﬁnger binding
sites. Oligonucleotides containing the zinc ﬁnger binding
sites and methylation site were annealed, phosphorylated
and ligated into the pDIM-N7 M.EcoHK31IA plasmid.
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N-terminus of the M.EcoHK31IA fragment either
directly (linker 0L) or using amino acid linkers of
various sizes. Linkers were designed to be ﬂexible and
are repeating GGGGS sequences to create linkers of the
length 5, 10 or 15 residues long (linkers 5, 10 or 15L). Zinc
ﬁnger protein Tyr456 was fused to the C-terminus of the
M.EcoHK31IB 42 (b42) fragment using identical
linkers as the Tyr123-a fusions. Linkers were appended
to the appropriate methyltransferase fragments and the
Tyr123 and Tyr456 zinc ﬁnger proteins by PCR.
Overlap extension PCR was then done to fuse the frag-
ments to the zinc ﬁngers, and fused constructs were ligated
into pDIM-N7 and pAR plasmids. This created 16
pDIM-N7 Tyr123-M.EcoHK31IA (pDIM-N7 Tyr123-a)
plasmids containing every possible combination of the
target site (0, 1, 2 or 3bp) and Tyr123-M.EcoHK31IA
linker length (0, 5, 10 or 15L) and four unique pAR
M.EcoHK31IB 42-Tyr456 (pAR b42-Tyr456)
plasmids with the four diﬀerent linker sizes. These
plasmids were cotransformed into ER2267 cells to form
a 64-member combinatorial M.EcoHK31I Tyr123-a/
b42-Tyr456 library.
Construction of plasmids for M.EcoHK31IB deletion
optimization and control plasmids
The EagI non-target site was modiﬁed so that the
overlapping NotI site was removed by changing base
pairs ﬂanking the EagI site to adenines. This created
identical ﬂanking nucleotides as the target EagI site
(Figure 2B). We also created several control plasmids to
test if the zinc ﬁnger binding sites and zinc ﬁnger proteins
were necessary for targeted methylation. Control target
sites lack the zinc ﬁnger binding sites but still contain
the EagI site with similar ﬂanking base pairs as the 3bp
target site (Figure 2B). The control target site
oligonucleotides were annealed, phosphorylated and
ligated into the pDIM-N7 Tyr123-15L-a plasmid in
place of the original target site. The M.EcoHK31IA gene
without Tyr123 was ampliﬁed and inserted into the
pDIM-N7 plasmids containing the 3bp target site and
the plasmid containing a control target site to create
the pDIM-N7 a plasmids.
New M.EcoHK31IB-5L-Tyr456 truncations were
created by amplifying the M.EcoHK31IB42-5L-Tyr456
fragment with the appropriate primers. Truncations were
created up to 70-amino acid residues and fusions were
ligated into the pAR plasmid. M.EcoHK31IB fragments
without zinc ﬁnger proteins were also ampliﬁed
and ligated into the pAR plasmid. A full length
M.EcoHK31IB-5L-Tyr456 fusion was also created by
amplifying the full length M.EcoHK31IB gene and
fusing to the Tyrzif456-5L fragment by overlap extension
PCR as performed before. The full-length fusion was then
inserted in the new pAR plasmid.
Creation of fusion pDIM-N7 plasmids
Fusion plasmids were made by digesting the desired
pDIM-N7 plasmid and pAR plasmid with EcoRI and
SpeI. The pAR plasmid section containing the desired
M.EcoHK31IB fusion gene, pBAD promoter and araC
gene is isolated by gel extraction using the QIAquick
Gel Extraction kit (Qiagen, Vaencia, CA, USA) and
ligated into the pDIM-N7 vector (Figure 3A).
Restriction endonuclease protection assays
All in vivo assays were performed using E. coli strain
ER2267 (New England Biolabs, Ipswich, MA, USA).
Plasmids were transformed into ER2267 cells. Cells were
grown from a glycerol stock in 25ml culture tubes in 10ml
of LB media supplemented with antibiotics as necessary to
maintain plasmids (100mg/ml ampicillin and 50mg/ml
chloramphenicol). In some experiments, 0.2–5% w/v
glucose was added as indicated to repress expression of
both methyltransferase fragments. In other experi-
ments, the media was supplemented with 1mM IPTG to
induce the lac promoter or 1mM arabinose to induce
the pBAD promoter. Cultures were incubated overnight
(12–14h) at 37 C and the plasmid DNA was isolated
using QIAprep spin miniprep kit (Qiagen, Valencia,
CA, USA).
For initial in vivo deletion studies with pDIM-N7
M.EcoHK31IA plasmids (Supplementary Figure S2A,
Supplementary Data), 500ng of DNA was incubated
with 3U of NotI. For cotransformed samples containing
the pDIM-N7 Tyr123-a or pDIM-N7 a plasmids, 2 mgo f
puriﬁed DNA were ﬁrst digested with 20U AfeI to
linearize pDIM-N7 plasmids and puriﬁed using the
DNA Clean and Concentrator kit (Zymo Research
Corp., Orange, CA, USA). Then, 500ng of linearized
DNA was digested with 12.5U of EagI and analyzed by
gel electrophoresis using a 0.8% agarose gel.
For cases in which both methyltransferase fragments
were encoded on the same plasmid, 500ng of DNA was
incubated with 3.75 U BsaAI and 12.5U of EagI to deter-
mine methylation at the target and non-target EagI sites.
Alternatively, plasmids were digested with 15U of XbaI
and 3.75 U of EaeI overnight at 37 C to probe protection
at all potential methylation sites. After digestion, 500ng
of DNA was analyzed by agarose gel electrophoresis using
a 0.8% agarose gel.
Bisulﬁte sequencing
Cultures of ER2267 containing the pDIM-N7-Tyr123-
15L-a/b67-5L-Tyr456 vector were grown in 10ml LB,
100 mg/ml ampicillin and 0.2% w/v glucose. Plasmid
DNA was recovered and digested to linearize DNA.
Bisulﬁte conversion was performed using the Epitect
Bisulﬁte Kit (Qiagen, Valencia, CA, USA) according to
manufacturer’s instructions. After the bisulﬁte conversion,
the target region (using primers Bisulﬁte Top Target-for
and Bisulﬁte Top Target-rev or Bisulﬁte Bottom
Target-for and Bisulﬁte Bottom Target-rev) and the
non-target region containing an EagI site (using primers
Bisulﬁte Non-Target-for and Bisulﬁte Non-Target-rev)
were ampliﬁed by PCR using Qiagen’s HotStarTaq
DNA polymerase. Primer sequences can be found in
Supplementary Table S4. The fragments were then
inserted into the pAR plasmid and transformed into
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for sequencing. Sequencing was performed by Genewiz
(South Plainﬁeld, NJ, USA).
RESULTS
M.EcoHK31I is functional in vivo when the two
fragments are encoded as separate genes.
The b fragment of M.EcoHK31I is entirely encoded in an
alternate reading frame within the DNA encoding the a
fragment (16). We placed DNA encoding the a- and
b-fragment of M.EcoHK31I on separate compatible
plasmids. The DNA encoding M.EcoHK31I was placed
downstream from the lac promoter on plasmid derived
from pDIM-N7-MHhaI[1–302] (22). This plasmid con-
tained an M.EcoHK31I methylation site that overlaps a
NotI site (Supplementary Figure S2A, Supplementary
Data); thus, methylation can be detected by observation
of protection from NotI digestion. The start codon for the
b protein was removed by silently mutating in the frame of
the a-subunit. However, this gene still conferred some
methylation activity to cells, since partial protection
from NotI digestion of the plasmid was observed. Since
the b fragment does not require the ﬁrst 42N-terminal
amino acids for activity in vitro (17), we suspected that
methionine codons at positions 17 or 26 in the b
fragment reading frame were serving as internal transla-
tion initiation sites. A gene in which these two sites were
removed by silently mutating in the a reading frame no
longer conferred any methylation activity as judged by
a lack of protection at the NotI site (Supplementary
Figure S2B, Supplementary Data). We refer to this
mutated gene as M.EcoHK31IA. DNA encoding just the
b fragment (referred to as M.EcoHK31IB) was placed
downstream from the pBAD promoter on a compatible
plasmid. Co-transformation of these plasmids into cells
resulted in plasmid DNA that showed complete protection
from NotI digestion (Supplementary Figure S2B,
Supplementary Data) demonstrating that our split gene
version of M.EcoHK31I methylates DNA in vivo.
Removal of 50 amino acids from the N-terminus of the
b fragment severely reduces but does not eliminate
methylation activity in vivo
We have previously shown that fragments of M.HhaI that
can assemble into a functional methyltransferase without
assistance retain the ability to methylate non-target sites
when fused to zinc ﬁnger domains (13). In order to
engineer our desired site-speciﬁc methyltransferase, we
required mutants of M.EcoHK31I that can no longer
assemble into a functional methyltransferase at cellular
concentrations. Studies on puriﬁed M.EcoHK31I have
shown that progressive deletion of amino acids from the
N-terminus of the b fragment results in a progressive
decrease in the association constant of the two fragments
(17). This correlates with a loss of methylation activity as
demonstrated by in vitro methylation assays. Almost no
activity was observed when 41 amino acids were deleted
from the b fragment and the protein was assayed at 1mM
concentration (the Kd for fragment interaction was
2.4mM) (17). Deletions of 42, 46 (Kd=5.3mM) and 50
(Kd=7.1mM) amino acids showed no activity at this
same concentration (17).
We created a series of variants of M.EcoHK31IB in
which up to 50 codons were deleted from the 50 end and
tested their ability to confer methylation activity to cells
expressing an intact a fragment. Cells were grown without
the addition of IPTG or arabinose (i.e. under non-inducing
conditions); thus, activity is dependent on the low-level,
leaky expression of the two fragments. Reduced protection
from NotI digestion was observed starting with the b37
truncation fragment and protection progressively
decreased with increasing truncation of the b fragment
(Supplementary Figure S2B, Supplementary Data). In
contrast to previous in vitro experiments (17), we observed
some protection with b42, b45 and b50. Potentially,
cellular concentrations of the fragments are higher than
concentrations used in the in vitro experiments.
Design of the methylation target site and fusion of the
a and b"42 fragments to zinc ﬁngers
Even though we did not obtain a truncation mutant that
completely lacked methylation activity in vivo, we thought
that the severely reduced activity obtained with b42 was
suﬃcient for testing whether fusing zinc ﬁngers to these
fragments could be used to bias the methylation to a target
site located between the zinc ﬁngers’ binding sites. The
plasmid encoding the a fragment was modiﬁed to
contain a target site for M.EcoHK31I methylation
ﬂanked by zinc ﬁnger binding sites (Figure 1A and B).
Four diﬀerent target sites were created diﬀering only in
the number of bp between the M.EcoHK31I site and the
zinc ﬁnger binding sites (Figure 1A). In all cases, this
target site was also an EagI site. EagI activity is blocked
by methylation—aﬀording an easy assay for methylation
at this site. A second ‘non-target’ M.EcoHK31I
methylation site with an EagI site was located elsewhere
on the plasmid such that digestion with EagI could be
used to determine which of the two sites was methylated
(Figure 1B).
M.EcoHK31IA and M.EcoHK31IB42 were fused to
zinc ﬁngers Tyr123 and Tyr456 (23), respectively, using
amino acid linkers of 0, 5, 10 or 15 residues consisting
of repeats of the sequence GGGGS. Tyr123 binds to the
sequence 50-GTGGATGAC-30 and Tyr456 binds 50-GAA
GGGGAA-30. Tyr123 was fused to the N-terminus of the
M.EcoHK31IA fragment and Tyr456 was attached to the
C-terminus of M.EcoHK31IB 42. In total, 16 diﬀerent
plasmids containing variants of the a fragment were
created (4 diﬀerent linkers between the a fragment and
Tyr123 4 diﬀerent spacing between the target site and
the zinc ﬁnger binding sites). These were cotransformed
with plasmids encoding the b42 fragment (four diﬀerent
linkers) into ER2267 cells resulting in 64 combinations of
target site spacing and linker lengths. Glycerol cell stocks
of these 64 diﬀerent cells were made from overnight
inocula grown in LB containing 0.2% glucose (to repress
the lac and pBAD promoters).
1752 Nucleic Acids Research, 2010,Vol.38, No. 5Figure 1. The eﬀect of fusion linker length and spacing at the target site on the methyltransferase activity and speciﬁcity of M.EcoHK31I-derived
constructs with a 42-residue deletion on the b fragment. (A) Schematic of the various constructs tested showing the variability in linker length
between zinc ﬁnger and methyltransferase fragments and the distance between the zinc ﬁnger’s binding site and the target site for methylation.
(B) The two plasmids encoding the two methyltransferase fragments and the DNA fragments that result from AfeI and EagI digestion if the EagI site
is not methylated (methylation blocks EagI but not AfeI digestion). Methylation creates uniquely sized bands depending on if the target or
non-target site is protected. Representative results are shown to demonstrate the observed eﬀects of (C) zinc ﬁnger–target site distance, (D) linker
lengths between the a fragment and Tyr123 and (E) linker lengths between the b fragment and Tyr456. Linker lengths are designated by 0, 5, 10 or
15L and the spacing at the target site designated by the number of base pairs between the target site and zinc ﬁnger site. Individual plasmids digested
with AfeI are also shown for size comparisons (pDIM-N7 and pAR) with (+) and without ( ) EagI digestion. The locations of bands resulting from
only target methylation, only non-target methylation and methylation at both sites are indicated. The plasmids were prepared from cells grown in LB
media.
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position of the zinc ﬁnger binding sites and the
target methylation site
LB media lacking glucose was inoculated with the
cotransformants and incubated overnight at 37 C.
The absence of glucose allowed leaky expression of the
Tyr123-a and b42-Tyr456 proteins. Plasmid DNA was
recovered, digested with AfeI restriction enzyme to
linearize the plasmid (AfeI is not blocked by
M.EcoHK31I activity), digested with EagI and analyzed
by agarose gel electrophoresis. Methylation at the target
and non-target sites can be distinguished by the size of
the bands that result (Figure 1B). Methylation at the
non-target site band results in a unique  3935bp band,
and methylation at the target site results in a unique
 3110bp band. Methylation at both sites results in a
 4550bp band. A lack of methylation at either site
results in three bands all  2500bp.
Representative results illustrating the major trends in
methylation activity and speciﬁcity observed in the 64 dif-
ferent construct combinations are shown in Figure 1C–E.
The distance between the zinc ﬁnger binding sites and the
target methylation site had the greatest aﬀect on
methylation speciﬁcity (Figure 1C). Short distances
(0 and 1bp) inhibited methylation at the target site and
resulted in a methylation only at the non-target site.
Longer distances (2 and 3bp) results in a mix of both
target and non-target site methylation, with a deﬁnite
bias toward target site methylation occurring with the
3bp spacing. We suspect that at short distances, zinc
ﬁnger binding to its cognate sites on the DNA may
block the methyltransferase from methylating at the
target site.
To a lesser extent, the length of the peptide linker
joining Tyr123 and the a subunit impacted methylation
speciﬁcity. This was most noticeable with the 3bp
distance between the zinc ﬁnger binding site and the
target site. Incomplete methylation at the target site is
evident with shorter linker lengths (0 and 5 amino acids)
whereas nearly complete methylation at the target site is
observed with the longer linkers (10 and 15 amino acids)
(Figure 1D). Methylation levels at the non-target site
appear unaﬀected by the linker length. These trends are
most evident by observing the gradual disappearance of
the band at  2500bp (indicating increasing methylation
at the target site) and the invariable levels of the 1435bp
band (indicating unchanging levels of non-target
methylation) as the linker length increases. The length
of the linkers between Tyr456 and b42 did not have a
signiﬁcant eﬀect on the methylation patterns in any
context (Figure 1E).
In all constructs, higher levels of methylation
were observed compared to constructs lacking zinc
ﬁngers. This is potentially due to the stabilization of
one or both of the M.EcoHK31I fragments by the
zinc ﬁnger domain, which would result in increased
fragment concentrations in the cells. The highest levels
of methylation and speciﬁcity for the target site was
observed with a 3bp spacing between the zinc ﬁnger
binding site and the target site and longer linker
lengths (10 or 15 residues) in the Tyr123-a fragment.
However, the occurrence of signiﬁcant levels of
non-target methylation prompted us to pursue further
optimization.
Further optimization by longer truncations of the
N-terminus of M.EcoHK31IB
To reduce non-speciﬁc methylation we created larger dele-
tions of M.EcoHK31IB. Since the addition of zinc ﬁngers
to the M.EcoHK31I fragments increased overall
methylation activity in the previous set of experiments,
the eﬀects of further truncations were performed with
the methyltransferase fragments fused to zinc ﬁngers.
Since the b42-Tyr456 linker lengths had little if any
eﬀect on target site methylation, a 5-residue linker
(GGGGS) was chosen for the M.EcoHK31IB-Tyr456
fusions. A pDIM-N7 plasmid containing the 3bp
spacing between the zinc ﬁnger binding site and the
target site and the Tyr123-15L-M.EcoHK31IA a subunit
was used. A control plasmid in which the zinc ﬁnger
binding sites were removed (control target site,
Figure 2B) was used to test for the level of methylation
independent of zinc ﬁnger binding.
Fusions of Tyr456 to M.EcoHK31IB containing dele-
tions of 50, 55, 60, 65 and 70 amino acids from the
N-terminus of the M.EcoHK31IB were constructed and
cotransformed with pDIM-N7 Tyr123-15L-a. Assays for
in vivo methylation were performed as before. Initial
experiments indicated that in the absence of the zinc
ﬁnger binding sites there was a slight and unexpected
bias toward methylation at the target site (data not
shown). Flanking base pairs to the cognate DNA recog-
nition sites can aﬀect restriction enzyme and methylation
activities, and we suspected that this was occurring with
M.EcoHK31I. In order to minimize these eﬀects, the
ﬂanking base pairs at the non-target site were changed
to match the target site. Changing the ﬂanking sites
eliminated the intrinsic methylation bias for the target
site and all subsequent experiments used plasmids contain-
ing this modiﬁed non-target site (EagI non-target site,
Figure 2B).
Using the pDIM-N7 plasmids with this new non-target
site, we evaluated the methylation activities of the more
extensive truncations of the b fragment. These experi-
ments were performed in the context of both a target
and non-target site so that both methylation activity and
methylation speciﬁcity could be evaluated. A progressive
decrease in methylation activity up to the deletion of 70
amino acids (Supplementary Figure S3A, Supplementary
Data) was observed. Target site methylation decreased
starting at the 65 amino acid deletion, and a signiﬁcant
decrease in methylation occurred between b65-
5L-Tyr456 and b70-5L-Tyr456. Truncation lengths
intermediate between 65 and 70 amino acids were also
tested (Supplementary Figure S3B, Supplementary Data)
and the b67-5L-Tyr456 showed similar target
methylation levels to b65-5L-Tyr456, but non-target
methylation appeared to be eliminated. Overall,
non-target methylation decreased more rapidly than
target methylation and seemed to disappear around
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decrease in target methylation with a signiﬁcant drop in
methylation between 69 and 70. We decided to
perform further studies on the Tyr123-15L-a and
b67-5L-Tyr456 combination since this pair seemed to
almost completely lack non-target methylation activity
while exhibiting signiﬁcant target site methylation activity.
Methylation speciﬁcity for the target site depends on
zinc ﬁnger binding
We next examined whether speciﬁcity for the target site
depended on the zinc ﬁnger proteins and the zinc ﬁnger
binding sites. All combinations of constructs (with and
without zinc ﬁnger binding sites ﬂanking the target site,
M.EcoHK31IA with and without fusion to the Tyr123
zinc ﬁnger, M.EcoHK31IB 67 with and without fusion
to the Tyr456 zinc ﬁnger) were created (Figure 2A and B).
These constructs were cotransformed and tested for tar-
get and non-target methylation. A combination of high
levels of target methylation (>50%) and a virtual lack
of methylation at the non-target site was seen only with
zinc ﬁngers fused to the fragments and the presence of
both zinc ﬁnger binding sites ﬂanking the target site.
Removal of the zinc ﬁnger binding sites eliminated
methylation at the target site as did removal of Tyr456
or both Tyr456 and Tyr123 (Figure 2C and D).
Removal of only Tyr123 resulted in low, but detectable,
levels of target site methylation (Figure 2D). This sug-
gests that although the Tyr456 zinc ﬁnger may be more
Figure 2. The eﬀects of removing zinc ﬁnger proteins or zinc ﬁnger binding sites on the methylation activity and speciﬁcity of M.EcoHK31I-derived
constructs with a 67-residue deletion on the b fragment. (A) Schematic of the fusion and control constructs used in these experiments. (B) DNA
sequences at the target sites (with and without zinc ﬁnger binding sites) and non-target site. All pDIM-N7 plasmids contain a non-target site and
either the target site containing zinc ﬁnger binding sites (+) or containing a control site for which the zinc ﬁngers lack aﬃnity (–). Gel electrophoresis
results for plasmids digested with AfeI and EagI (performed as in Figure 1) are shown for plasmids containing the DNA encoding (C) Tyr123-15L-a
and (D) a cotransformed with plasmids encoding b67 or b67-5L-Tyr456. Results for AfeI or AfeI/EagI digestions of unmethylated control
plasmids are shown for size comparison. The locations of bands resulting from only target methylation, only non-target methylation and methylation
at both sites are indicated. The plasmids were isolated from cells grown in LB media.
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two zinc ﬁngers is synergistic for targeting methylation.
Methylation speciﬁcity is aﬀected by gene copy
number and induction levels
For the next set of experiments, we combined the
Tyr123-15L-  and  D67-5L-Tyr456 genes onto a single
plasmid. A one-vector system is preferable to maintaining
two plasmids in cells. The pDIM-N7 and pAR plasmids
were designed to allow the facile construction of a single
expression vector containing the Tyr123-15L-a and
b67-5L-Tyr456 and other fragment variants. The
pDIM-N7 and pAR plasmids were digested and the
pAR plasmid section containing the methyltransferase
gene, pBAD promoter and AraC gene were ligated into
the pDIM-N7 plasmid to form the pDIM-N7 a/b ZF
plasmids. The plasmids contain the same target and
non-target EagI sites, but a diﬀerent enzyme was needed
to linearize the larger fragment to create unique-size target
and non-target bands for analysis. The plasmid was ﬁrst
digested with BsaAI, which excised the b fragment gene
(Figure 3A). Subsequent digestion with EagI was used to
distinguish between target and non-target methylation
(Figure 3A).
The pAR plasmid has a lower copy number than the
pDIM-N7 plasmid. Thus, an increase in the protein levels
of the M.EcoHK31IB fragments was expected to result
from placing the b fragment gene together with the a
fragment gene on the pDIM-N7 plasmid. Growth of
cells bearing the pDIM-N7 a/b ZF plasmids under the
same conditions as the previous experiments with the
cotransformed plasmids (i.e. leaky expression) resulted in
continued high level of methylation at the target site, but
detectable protection at the non-target site. However, by
repressing expression with 0.2% glucose, non-target
methylation could be eliminated, although low levels
of methylation were detected in some experiments
(Supplementary Figure S4A, Supplementary Data).
Increasing the concentration from 0.2% to 5% (w/v) did
not result in the loss of any target methylation but pre-
vented non-target methylation (Supplementary Figure
S4B, Supplementary Data). This indicates that high
levels of glucose can be used to ensure minimal non-target
methylation. Induction with either 1mM IPTG, 1mM
arabinose or both increased non-target methylation but
did not have a signiﬁcant eﬀect on target methylation
(Supplementary Figure S4A, Supplementary Data). In
the absence of the zinc ﬁnger binding sites ﬂanking the
target site and in the absence of any glucose repression,
equally low levels of methylation occurred at the target
and non-target sites. Although induction reduced the
level of speciﬁcity for the desired target site, under all
conditions methylation at the target site ﬂanked by zinc
ﬁnger binding sites was preferred over methylation at the
non-target site. Maintenance of bias for target
methylation over a wide range of expression conditions
would not be expected for fusions of intact
methyltransferase domains to zinc ﬁngers. High level of
expression of such fusions would result in the opportunity
for the methyltransferase domain in the fusion to
extensively methylate non-target sites.
We also created a single plasmid encoding full-length
fragments b-5L-Tyr456 (i.e. no truncation of the b
fragment) and Tyr123-15L-a and tested them for
methylation activity in cultures grown in media with dif-
ferent glucose levels. Plasmids recovered from cells grown
in 0.2% w/v and 5% w/v glucose were fully protected from
EagI digestion (Supplementary Figure S5, Supplementary
Data) indicating no speciﬁcity, as expected. This indicates
that the reduction in methylation at the non-target site is
due to the deletions made to the M.EcoHK31IB fragment.
We next sought to probe the eﬀects of the zinc ﬁngers
and zinc ﬁnger binding sites in the new one-plasmid
systems, similar to experiments performed with
cotransformed plasmids in Figure 2. We performed these
experiments at the glucose levels at which faint non-target
methylation was sometimes previously observed: LB sup-
plemented with 0.2% glucose. Methylation occurred only
when zinc ﬁnger binding sites were present (Figure 3B)
and non-target methylation was not observed under any
conditions. Full protection at the target site was not
observed. Analysis of the band intensities indicated that
50–60% of the target sites were methylated. Small
amounts ( 10%) of target site methylation were
observed when either the Tyr123 or Tyr456 zinc ﬁngers
(but not both) were removed (Figure 3B and C). As was
observed using the two-plasmid system, both zinc ﬁngers
were not required for some bias toward methylation at the
target site. However, the two zinc ﬁngers synergistically
acted to direct methylation to the target site, since protec-
tion with both zinc ﬁngers exceeded the level expected by
adding the level of protection seen with each zinc ﬁnger
individually. Such a synergistic eﬀect is the basis for the
increase speciﬁcity that the split methyltransferase strategy
oﬀers.
Conﬁrmation of methylation speciﬁcity by bisulﬁte
sequencing
To conﬁrm that the protection observed in restriction
endonuclease assays resulted from methylation at the
EagI sites, we performed bisulﬁte sequencing on the
pDIM-N7 Tyr123-15L-a/b67-5L-Tyr456 plasmid
isolated from cells grown in LB media supplemented
with 0.2% glucose. We sequenced both the target site
(n=10 on each strand) and the non-target site (n=10).
None of the non-target site clones sequenced was
methylated. We sequenced the target site and probed
both the top and bottom strands (of the sequence
depicted in Figure 2B). We found that 4 out of 10
bottom strand clones and 1 out of 10 top strand clones
showed methylation at the target site. These results
conﬁrm that of the restriction enzyme protection assays
and suggest that there may be a bias toward methylating
one strand over the other.
Tyr123-15L-a/b"67-5L-Tyr456 preferentially methylates
the target site over other non-target sites
We next examined whether methylation was occurring
at other M.EcoHK31I sites on the pDIM-N7 a/b ZF
1756 Nucleic Acids Research, 2010,Vol.38, No. 5plasmid. There are ﬁve potential methylation sites on this
plasmid and EaeI can digest all sites (50-YGGCCR-30), but
only if they are not methylated. The EaeI restriction
enzyme was not generally useful in previous experiments
since the enzyme digests some sequences slower than
others (24)—requiring DNA to be incubated overnight
to ensure complete digestion. EaeI was useful here for
probing methylation at previously unassayed non-target
sites, since protection at either of two such sites (marked
with an * in Figure 4A) would result in bands clearly dis-
tinguishable from the target methylation band. Analysis of
the EaeI digestion of plasmids encoding Tyr123-15L-a
and b67-5L-Tyr456 showed a clear band where the
target site band would occur and only a very faint band
at about the size expected for methylation at these two
non-target sites (Figure 4B). Thus, our construct exhibits
speciﬁcity for the target site over other M.EcoHK31I sites
on the plasmid in addition to the previously studied
non-target site. In contrast, full-length fragments
attached to zinc ﬁngers (Tyr123-5L-a and b-5L-Tyr456)
fully protect plasmids from digestion with EaeI
(Figure 4B).
DISCUSSION AND CONCLUSIONS
Several studies have examined the eﬀect of zinc ﬁnger–
methyltransferase fusions on the methylation patterns in
cells that have endogenous mechanisms for methylating
their DNA (4,5,7). The strength of these studies lies in
the examination of the fusions’ eﬀect in the cell type for
which they are intended. However, these studies are
limited in their ability to address the fusions’ inherent
methylation speciﬁcity in a cellular environment, since it
is hard to distinguish between methylation in a region
Figure 3. Methylation activity and speciﬁcity resulting from a single plasmid encoding Tyr123-15L-a and b67-5L-Tyr456 (A). Schematic of the
plasmid and its digestion with BsaAI (not-blocked by methylation) and EagI (blocked by methylation). Gel electrophoresis results for plasmids
digested with BsaAI and EagI are shown for plasmids contain the DNA encoding (B) Tyr123-15L-a and (C) a Combinations with DNA encoding
either b67 or b67-5L-Tyr456 and with and without zinc ﬁnger binding sites ﬂanking the target site were tested. The locations of bands resulting
from only target methylation, only non-target methylation and methylation at both sites are indicated. Plasmids were isolated from cells grown in LB
media supplemented with 0.2% glucose.
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non-speciﬁcally and methylation resulting from very
speciﬁc exogenous methylation spreading in a region due
to endogenous methyltransferase activity. The study of
such fusions’ eﬀects in yeast (11,25) and E. coli (6),
which lack endogenous methylation at the target site for
exogenous methylation, have not shown that such fusions
can achieve both high levels of target site methylation and
high speciﬁcity for the target site. This is not surprising
since methylation by these fusions does not inherently
require association of the zinc ﬁnger to its cognate site.
Optimal site-biased methylation in such fusions should
occur when the fusion concentration is kept low enough
such that few fusion molecules exist that are not bound
to the target site through the zinc ﬁnger. Reduction of
methyltransferase activity (6) can be used for a similar
purpose when fusion protein concentrations is higher
(i.e. although there are more free fusion molecules, their
intrinsic ability to methylate is decreased). However,
these optimizations do not address the inherent limitation
of the approach.
The split methyltransferase strategy described here
addresses this problem by incorporating a mechanism
for limiting the activity of free methyltransferase
proteins and requiring binding to the desired target site
for the assembly of an active methyltransferase. We have
engineered a construct capable of methylating a high
fraction of the target site (>50%) with undetectable
levels of non-target methylation. This activity depended
on the proper location of the zinc ﬁngers’ cognate
binding site relative to the target site for methylation.
The synergistic eﬀect of the two zinc ﬁngers on target
site methylation is exactly the advantageous property
this strategy promises. Our results are a signiﬁcant step
forward toward the goal of methylating unique sites
within a genome.
However, limitations of our fusions are apparent.
Although it is encouraging that a bias for target
methylation could be maintained over a wide range of
induction conditions, expression of the fragments needed
to be kept low to completely avoid non-target site
methylation. In addition, speciﬁc methylation of a
unique site in the human genome will require that both
zinc ﬁnger fusions be bound to their cognate sites for
targeted methylation to occur. This is reminiscent of the
mechanism of the action of zinc ﬁnger nucleases (ZFNs),
which requires that two ZFNs be bound to their cognate
sites for dimerization of the nuclease domain and eﬃcient
cleavage of the target site (23). Our constructs with only
one zinc ﬁnger still biased methylation to the target site.
One possible explanation is that non-targeted methylation
results from the assembly of free Tyr123-15L-a and
b67-5L-Tyr456 in solution. Alternatively, an assembled
methyltransferase domain bound through its zinc ﬁngers
at the target site on one plasmid may be capable of
methylating a non-target site on a second nearby
plasmid. For ultimate success of the strategy, not only
do we need to minimize activity in the absence of
binding of the zinc ﬁnger domain to its cognate site on
the DNA but we also need to constrain the reassembled
Figure 4. Tyr123-15L-a/b67-5L-Tyr456 has a high preference for the target site over other M.EcoHK31I methylation sites. (A) The pDIM-N7
plasmid contains ﬁve methylation sites for M.EcoHK31I that overlap EaeI restriction enzyme sites (EaeI is blocked by methylation) and one XbaI
site used to linearize the plasmid and facilitate analysis. The sizes of the ﬁve largest DNA fragments that result from XbaI/EaeI digestion of
unmethylated DNA are shown. (B) Agarose gel electrophoresis results of XbaI/EaeI digestions of plasmids expressing Tyr123-15L-a/
b67-5L-Tyr456 or Tyr123-15L-a/b-5L-Tyr456 (i.e. control protein with no truncation of the b fragment). Methylation at the target site yields a
2499bp band if the ﬂanking sites are not methylated. Methylation at the two EaeI sites marked with an asterisk would result in bands at either
3231bp or 3561bp if their ﬂanking sites are not methylated. These two EaeI sites are non-target sites that were not tested in previous experiments.
Plasmids were isolated from cells grown in LB media supplemented with 0.2% glucose.
1758 Nucleic Acids Research, 2010,Vol.38, No. 5methyltransferase such that it can only methylate its tar-
get site and cannot methylate DNA that might come
in proximity to the methyltransferase. This might be diﬃ-
cult to overcome with a split enzyme such as
M.EcoHK31I for which structural information is
lacking. Further modiﬁcation of the M.EcoHK31I-zinc
ﬁnger fragments using random mutagenesis or other
directed evolution methods might oﬀer the best
approach for creating fragments with higher speciﬁcity.
However, M.EcoHK31I is limited by the
methyltransferase’s inherent speciﬁcity. Ultimately it
might be best to apply this approach for well-studied,
structurally characterized CpG methyltransferases that
have been artiﬁcially split such as HhaI methyl transferase
(13,22) but whether the artiﬁciality of such split
methyltransferases will present additional challenges
remains to be seen.
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